Physician profile
Timothy Grayson
NPI 1073597753
$8,165.09
in general payments reported to CMS, 2019-2025
30 companies · $2,722 in 2025
The $2,722 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $196 · 2021: $223 · 2022: $478 · 2023: $639 · 2024: $3,608 · 2025: $2,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,263 · Travel and Lodging: $2,589 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,263.23 |
| Travel and Lodging | $2,588.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,006.71 | 2024-2025 | Nanoknife |
| Boston Scientific Corporation | $1,667.37 | 2019-2025 | Xpeeda Dsl Fiber, Spaceoar Vue System - 10ml, Moses |
| Procept Biorobotics Corporation | $1,310.60 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $664.60 | 2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $436.56 | 2019-2024 | Xtandi, Veozah |
| Teleflex LLC | $412.02 | 2023-2025 | Urolift |
| Endo Pharmaceuticals INC. | $218.76 | 2019-2022 | |
| Ge Healthcare | $183.77 | 2025 | |
| Janssen Biotech, INC. | $168.37 | 2019-2023 | Erleada |
| Sumitomo Pharma America, INC. | $133.04 | 2023-2024 | Orgovyx |
| Pfizer INC. | $130.34 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $99.71 | 2022-2025 | Urgent Pc Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $97.92 | 2021-2025 | Porges Coloplast |
| Urogen Pharma, INC. | $82.69 | 2025 | |
| Myriad Genetic Laboratories, INC. | $68.89 | 2023 | Prolaris |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $66.17 | 2024-2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $60.56 | 2019-2025 | Bard Urinary Drainage Bag |
| Becton, Dickinson and Company | $49.75 | 2023-2025 | Bard Urinary Drainage Bag |
| Neotract INC. | $48.58 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $45.33 | 2022 | |
| Halozyme INC | $41.42 | 2023 | |
| Endo USA, INC. | $38.76 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $35.37 | 2022-2025 | Keytruda |
| Tolmar, INC. | $21.84 | 2023 | |
| Ethicon US, LLC | $16.89 | 2025 | Vistaseal, Ethicon, Surgicel Nu-Knit |
| Urovant Sciences INC | $16.14 | 2022 | |
| Rgh Enterprises LLC | $14.18 | 2020 | |
| Convatec INC. | $13.52 | 2023 | |
| Allergan, INC. | $11.41 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Grayson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.